Literature DB >> 17394243

Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease.

Randall S Meisner1, Bret J Spier, Sigurdur Einarsson, Erica N Roberson, Scott B Perlman, Jesus A Bianco, Andrew J Taylor, Michael Einstein, Christine J Jaskowiak, Kathleen M Massoth, Mark Reichelderfer.   

Abstract

BACKGROUND: A pilot study was performed investigating the possibility that positron emission tomography (PET) activity using 18-fluorodeoxyglucose (FDG) with nearly simultaneous computerized tomography (CT) for anatomic accuracy would identify regions of active inflammation in both ulcerative colitis (UC) and Crohn's disease (CD).
METHODS: Prospective clinical data was collected in 12 patients experiencing an exacerbation of their inflammatory bowel disease; 7 with CD and 5 with UC. A PET/CT scan (GE Discovery LS PET/CT scanner) was performed in all patients. Twenty patients undergoing PET/CT because of solitary pulmonary nodules served as controls. We graded the small bowel and 4 colon regions (ascending, transverse, descending, and rectosigmoid) with PET activity scores assigned to each region based on the amount of FDG uptake using the liver as the reference organ.
RESULTS: In UC patients, PET activity was seen in 13 of 24 (52%) regions. There was high (23 of 24; 95.8%) correlation between PET activity and disease activity as determined by colonoscopy, disease activity indices, and radiology. In patients with CD, PET activity was seen in 19 of 32 (59.4%) regions. Again, there was a high (26 of 32; 81.3%) correlation between PET activity and clinical disease activity. Of the 20 controls, significant PET activity (Grades 2 and 3) was seen in only 2 of 100 regions (2%).
CONCLUSIONS: We found that PET activity correlated well with active inflammation in both UC and CD, suggesting that this may be a noninvasive method of identifying disease activity in patients with inflammatory bowel disease.

Entities:  

Mesh:

Year:  2007        PMID: 17394243     DOI: 10.1002/ibd.20134

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  19 in total

Review 1.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

2.  Active ulcerative colitis diagnosed by (18)F-FDG PET/CT in an anti-TNF alpha treated patient with no visible luminal lesions on colonoscopy.

Authors:  Peter Parbo; Katrine Stribolt; Charlotte Siggaard Rittig; Lars Christian Gormsen
Journal:  Int J Colorectal Dis       Date:  2014-02-16       Impact factor: 2.571

3.  Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease.

Authors:  Robert T Lapp; Bret J Spier; Scott B Perlman; Christine J Jaskowiak; Mark Reichelderfer
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

4.  FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

Authors:  Babak Saboury; Ali Salavati; Alex Brothers; Sandip Basu; Thomas C Kwee; Marnix G E H Lam; Roland Hustinx; Edouard Louis; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-20       Impact factor: 9.236

Review 5.  Current tecniques and new perpectives research of magnetic resonance enterography in pediatric Crohn's disease.

Authors:  Gabriele Masselli; Ilaria Mastroiacovo; Emidio De Marco; Giulia Francione; Emanuele Casciani; Elisabetta Polettini; Gianfranco Gualdi
Journal:  World J Radiol       Date:  2016-07-28

6.  Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI.

Authors:  Deepak K Kadayakkara; Sarangarajan Ranganathan; Won-Bin Young; Eric T Ahrens
Journal:  Lab Invest       Date:  2012-02-13       Impact factor: 5.662

7.  Epithelial uptake of [18F]1-(2'-deoxy-2'-arabinofuranosyl) cytosine indicates intestinal inflammation in mice.

Authors:  Sarah Brewer; Evan Nair-Gill; Bo Wei; Ling Chen; Xiaoxiao Li; Mireille Riedinger; Dean O Campbell; Stephanie Wiltzius; Nagichettiar Satyamurthy; Michael E Phelps; Caius Radu; Owen N Witte; Jonathan Braun
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

8.  PET/MR Versus PET/CT Imaging: Impact on the Clinical Management of Small-Bowel Crohn's Disease.

Authors:  Gianluca Pellino; Emanuele Nicolai; Onofrio A Catalano; Severo Campione; Francesco P D'Armiento; Marco Salvatore; Alberto Cuocolo; Francesco Selvaggi
Journal:  J Crohns Colitis       Date:  2015-11-15       Impact factor: 9.071

Review 9.  Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

Authors:  C G Cronin; J Scott; A Kambadakone; O A Catalano; D Sahani; M A Blake; S McDermott
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

10.  PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment.

Authors:  Bret J Spier; Scott B Perlman; Christine J Jaskowiak; Mark Reichelderfer
Journal:  Mol Imaging Biol       Date:  2009-05-09       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.